|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vitro biome- chanical comparison of an anterior and anterolateral lumbar plate with posterior fixation following single-level anterior lumbar interbody fusion显示文摘 | Johnson WM Nichols TA Jethwani D | 2007 | J Neurosurg Spine2007，7，3： | 1 |
| 2 | Evaluating a web-based self-management program for employees with hypertension and prehypertension: A randomized clinical trial显示文摘 | Alice J. Watson Kanwaljit Singh Khinlei Myint-U Richard W. Grant Kamal Jethwani Ellen Murachver Kimberly Harris Thomas H. Lee Joseph C. Kvedar | 2012 | American Heart Journal2012，，4： | 1 |
| 3 | Understanding family functioning and social support in unremitting schizophrenia:a study in India显示文摘 | Sawant NS Jethwani KS | 2010 | Indian J Psychiatry2010，52，2： | 1 |
| 4 | Assessment of biofilm formation by the causative organisms of ventilator associated pneumonia at Intensive Care Unit of a tertiary care hospital显示文摘 | Mulla Summaiya A Jethwani Urmi N | | 0，，01： | 1 |
| 5 | Long-running telemedicine networks delivering humanitarian services:experience,performance and scientific output显示文摘 | Richard Wootton Antoine Geissbuhler Kamal Jethwani | | 0，，05： | 1 |
| 6 | Invitro biomechanical comparison of an anterior and anterolateral lumbar plate with posterior fixation following single - level anterior lumbar interbody fusion 显示文摘 | Johnson WM Nichols TA Jethwani D | 2007 | J Neurosurg Spine2007，7，： | 1 |
| 7 | In vitro biome- chanicalcomparison of an anterior and anterolateral lumbar plate withposterior fixation following single - level anterior lumbar interbodyfusion 显示文摘 | Johnson WM Nichols TA Jethwani D | 2007 | J Neurosurg Spine2007，25，7： | 1 |
| 8 | Oral care practices and Alc among youth with type 1 and type 2 diabetes 显示文摘 | Merchant AT Oranbandid S Jethwani M | 2012 | J Periodon- tol2012，83，7： | 1 |
| 9 | In vitro biomechanical comparison of an anterior and anterolateral lumbar plate with posterior fixation following single - level anterior lumbar interbody fusion 显示文摘 | Johnson WM Nichols TA Jethwani D | 2007 | J Neurosurg Spine2007，7，： | 1 |
| 10 | In vitro biomechanieal comparison of an anterior and anterolateral lumbar plate with posterior fixation following single-level anterior lumbar interbody fusion 显示文摘 | Johnson WM Nichols TA Jethwani D | 2007 | J Neurosurg Sping2007，7，3： | 1 |
| 11 | In vitro biomechanical comparison of an anterior and anterolateral lumbar plate with posterior fixation following single-level anterior lumbar interbody fusion显示文摘 | Johnson WM Nichols TA Jethwani D | | 0，，： | 1 |
| 12 | Understanding family functioning and social support in unremitting schizophrenia: A study in India显示文摘 | Sawant N S Jethwani K S | 2010 | Indian J Psychiatry2010，52，2： | 1 |
| 13 | Dehydroepiandrosterone sulfate supplementation in health and diseases显示文摘Dehydroepiandrosterone sulfate(DHEAS)is a hormone produced by the zona reticularis of the adrenal gland and the ovaries.Initially considered as an inert compound merely serving as an intermediate in the conversion of cholesterol to androgens,interest in DHEA began to grow in the 1960s when it was found that DHEAS is the most abundant steroid hormone in human plasma and that its levels decline with age.In many countries,DHEA is considered a nutritional supplement.It has been used for a multitude of conditions which include sexual dysfunction,infertility,genitourinary syndrome of menopause,musculoskeletal disorders,cardiovascular diseases,ageing,neurological diseases,autoimmune conditions,adrenal insufficiency,and anorexia nervosa.We describe an overview of the historical evolution of DHEA,its physiology,and the disease states where it has been evaluated as a supplement. | Parth Jethwani Ashu Rastogi Ravindra Shukla | 2023 | World Journal of Meta-Analysis2023，11，4： | 0 |
| 14 | Non-medicalization of medical science:Rationalization for future显示文摘As we delve into the intricacies of human disease,millions of people continue to be diagnosed as having what are labelled as pre-conditions or sub-clinical entities and may receive treatments designed to prevent further progression to clinical disease,but with debatable impact and consequences.Endocrinology is no different,with almost every organ system and associated diseases having subclinical entities.Although the expansion of these“grey”pre-conditions and their treatments come with a better understanding of pathophysiologic processes,they also entail financial costs and drug adverse-effects,and lack true prevention,thus refuting the very foundation of Medicine laid by Hippocrates“Primum non nocere”(Latin),i.e.,do no harm.Subclinical hypothyroidism,prediabetes,osteopenia,and minimal autonomous cortisol excess are some of the endocrine preclinical conditions which do not require active pharmacological management in the vast majority.In fact,progression to clinical disease is seen in only a small minority with reversal to normality in most.Giving drugs also does not lead to true prevention by changing the course of future disease.The goal of the medical fraternity thus as a whole should be to bring this large chunk of humanity out of the hospitals towards leading a healthy lifestyle and away from the label of a medical disease condition. | Madhukar Mittal Parth Jethwani Dukhabandhu Naik MK Garg | 2022 | World Journal of Methodology2022，12，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员